Keywords
Medicinal Chemistry Drugs, Diseases Healthcare Treatment Therapy
Dear Editor,
In today's rapidly advancing world, medicinal chemistry is crucial in developing and discovering life-saving drugs (1, 2). Medicinal chemists combine chemistry and biology to design and synthesize compounds that target specific biological pathways and processes (3, 4). Medicinal chemistry is shaping the therapy world in remarkable ways, revolutionizing healthcare and improving the quality of life for millions of people worldwide. Design and synthesis of small molecules that specifically target disease-causing molecules or pathways is one of the critical contributions of medicinal chemistry. The molecules, known as drug candidates, undergo extensive optimization to minimize side effects and maximize efficacy (4, 5). Medicinal chemists collaborate closely with biologists and pharmacologists to understand the intricate mechanisms of diseases and identify suitable targets for drug intervention (2). A rational design approach and study of structure-activity relationships are used to modify and optimize molecules for therapeutic purposes (4, 6).
Medicinal chemistry has significantly advanced the understanding and treatment of various diseases (7). For example, medicinal chemists have developed targeted therapies in oncology, which selectively inhibit specific molecular pathways involved in cancer cell growth and proliferation (5, 8, 9). This approach has revolutionized cancer treatment, leading to improved survival rates and reduced toxicity compared to traditional chemotherapy (10, 11). Medicines such as imatinib, which cures chronic myeloid leukemia, and trastuzumab, which treats HER2-positive breast cancer, are prime examples of how medicinal chemistry has revolutionized treatments for cancer (12, 13). Moreover, medicinal chemistry has been pivotal in developing antiviral drugs, particularly during the ongoing COVID-19 pandemic (14, 15). In record time, medicinal chemists collaborated with virologists and other experts to identify potential drug targets for the Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) responsible for COVID-19 (14). The team utilized their knowledge of viral replication mechanisms and structure-based drug design to rapidly design and synthesize antiviral compounds that have shown promising results in combating the virus, such as remdesivir and molnupiravir (16, 17).
Additionally, medicinal chemistry has significantly contributed to neuroscience and mental health (5). Drugs that target specific receptors and neurotransmitter systems have been developed to alleviate the symptoms of neurological disorders such as Alzheimer's disease, Parkinson's disease, and depression (18-20). Some of these drugs improve patients' quality of life and provide valuable insights into the underlying mechanisms of these complex disorders (21). Furthermore, the emergence of drug-resistant pathogens has posed a significant threat to global health (22). Medicinal chemists actively combat antimicrobial resistance by designing novel antibiotics and exploring alternative treatment strategies. Several innovative approaches are being used to develop effective therapies against resistant bacteria, viruses, and fungi, including structure-based drug design, fragment-based drug discovery, and repurposing existing drugs (23). Medicinal chemistry is also critical in drug safety and optimization (24). Medicinal chemists can design compounds with improved pharmacokinetic properties to reduce toxicity and enhance therapeutic effectiveness by understanding drug metabolism in the body. Prodrugs, inactive compounds transformed into active drugs in the body, can also improve drug delivery and patient compliance (25, 26).
Based on the results, medicinal chemistry is at the forefront of shaping the therapy world. Medicinal chemists have made remarkable advancements in discovering and developing life-saving drugs through the fusion of chemistry, biology, and pharmacology. Patients worldwide benefit from their contributions to oncology, infectious diseases, neurology, and drug resistance. Medicinal chemistry will remain a driving force in the quest for improved therapies and a healthier future for all as technology and scientific knowledge evolve.
References
-
1.
Fernandes JPS. The Importance of Medicinal Chemistry Knowledge in the Clinical Pharmacist's Education. Am J Pharm Educ. 2018;82(2):6083. [PubMed ID: 29606703]. [PubMed Central ID: PMC5869745]. https://doi.org/10.5688/ajpe6083.
-
2.
Khan MO, Deimling MJ, Philip A. Medicinal chemistry and the pharmacy curriculum. Am J Pharm Educ. 2011;75(8):161. [PubMed ID: 22102751]. [PubMed Central ID: PMC3220342]. https://doi.org/10.5688/ajpe758161.
-
3.
Zhou SF, Zhong WZ. Drug Design and Discovery: Principles and Applications. Molecules. 2017;22(2). [PubMed ID: 28208821]. [PubMed Central ID: PMC6155886]. https://doi.org/10.3390/molecules22020279.
-
4.
Satyanarayanajois SD, Hill RA. Medicinal chemistry for 2020. Future Med Chem. 2011;3(14):1765-86. [PubMed ID: 22004084]. [PubMed Central ID: PMC3230884]. https://doi.org/10.4155/fmc.11.135.
-
5.
Vanden Eynde JJ, Mangoni AA, Rautio J, Leprince J, Azuma Y, García-Sosa AT, et al. Breakthroughs in medicinal chemistry: New targets and mechanisms, new drugs, new hopes–6. Molecules. 2019;25(1):119.
-
6.
Ohlmeyer M, Zhou MM. Integration of small-molecule discovery in academic biomedical research. Mt Sinai J Med. 2010;77(4):350-7. [PubMed ID: 20687180]. [PubMed Central ID: PMC2917822]. https://doi.org/10.1002/msj.20197.
-
7.
Moreira VM. What is medicinal chemistry?–Demystifying a rapidly evolving discipline!. MedChemComm. 2017;(9).
-
8.
Muhammad TA, Anusha C, Anup K. Cancer Chemotherapy. Treasure Island (FL): StatPearls; 2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK564367/.
-
9.
Stine ZE, Schug ZT, Salvino JM, Dang CV. Targeting cancer metabolism in the era of precision oncology. Nat Rev Drug Discov. 2022;21(2):141-62. [PubMed ID: 34862480]. [PubMed Central ID: PMC8641543]. https://doi.org/10.1038/s41573-021-00339-6.
-
10.
Debela DT, Muzazu SG, Heraro KD, Ndalama MT, Mesele BW, Haile DC, et al. New approaches and procedures for cancer treatment: Current perspectives. SAGE Open Med. 2021;9:20503121211034400. [PubMed ID: 34408877]. [PubMed Central ID: PMC8366192]. https://doi.org/10.1177/20503121211034366.
-
11.
Falzone L, Salomone S, Libra M. Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium. Front Pharmacol. 2018;9:1300. [PubMed ID: 30483135]. [PubMed Central ID: PMC6243123]. https://doi.org/10.3389/fphar.2018.01300.
-
12.
Viossat Y, Noble R. A theoretical analysis of tumour containment. Nat Ecol Evol. 2021;5(6):826-35. [PubMed ID: 33846605]. [PubMed Central ID: PMC8967123]. https://doi.org/10.1038/s41559-021-01428-w.
-
13.
Cao Y, Li Y, Liu R, Zhou J, Wang K. Preclinical and Basic Research Strategies for Overcoming Resistance to Targeted Therapies in HER2-Positive Breast Cancer. Cancers (Basel). 2023;15(9). [PubMed ID: 37174034]. [PubMed Central ID: PMC10177527]. https://doi.org/10.3390/cancers15092568.
-
14.
Ghosh AK, Brindisi M, Shahabi D, Chapman ME, Mesecar AD. Drug Development and Medicinal Chemistry Efforts toward SARS-Coronavirus and Covid-19 Therapeutics. ChemMedChem. 2020;15(11):907-32. [PubMed ID: 32324951]. [PubMed Central ID: PMC7264561]. https://doi.org/10.1002/cmdc.202000223.
-
15.
Gao S, Huang T, Song L, Xu S, Cheng Y, Cherukupalli S, et al. Medicinal chemistry strategies towards the development of effective SARS-CoV-2 inhibitors. Acta Pharm Sin B. 2022;12(2):581-99. [PubMed ID: 34485029]. [PubMed Central ID: PMC8405450]. https://doi.org/10.1016/j.apsb.2021.08.027.
-
16.
Ng TI, Correia I, Seagal J, DeGoey DA, Schrimpf MR, Hardee DJ, et al. Antiviral Drug Discovery for the Treatment of COVID-19 Infections. Viruses. 2022;14(5). [PubMed ID: 35632703]. [PubMed Central ID: PMC9143071]. https://doi.org/10.3390/v14050961.
-
17.
Hall MD, Anderson JM, Anderson A, Baker D, Bradner J, Brimacombe KR, et al. Report of the National Institutes of Health SARS-CoV-2 Antiviral Therapeutics Summit. J Infect Dis. 2021;224(Supplement_1):S1-S21. [PubMed ID: 34111271]. [PubMed Central ID: PMC8280938]. https://doi.org/10.1093/infdis/jiab305.
-
18.
Merighi S, Borea PA, Varani K, Vincenzi F, Travagli A, Nigro M, et al. Pathophysiological Role and Medicinal Chemistry of A(2A) Adenosine Receptor Antagonists in Alzheimer's Disease. Molecules. 2022;27(9). [PubMed ID: 35566035]. [PubMed Central ID: PMC9102440]. https://doi.org/10.3390/molecules27092680.
-
19.
Kandimalla R, Reddy PH. Therapeutics of Neurotransmitters in Alzheimer's Disease. J Alzheimers Dis. 2017;57(4):1049-69. [PubMed ID: 28211810]. [PubMed Central ID: PMC5793221]. https://doi.org/10.3233/JAD-161118.
-
20.
Spuch C, Navarro C. Liposomes for Targeted Delivery of Active Agents against Neurodegenerative Diseases (Alzheimer's Disease and Parkinson's Disease). J Drug Deliv. 2011;2011:469679. [PubMed ID: 22203906]. [PubMed Central ID: PMC3238398]. https://doi.org/10.1155/2011/469679.
-
21.
Cruz-Vicente P, Passarinha LA, Silvestre S, Gallardo E. Recent Developments in New Therapeutic Agents against Alzheimer and Parkinson Diseases: In-Silico Approaches. Molecules. 2021;26(8). [PubMed ID: 33920326]. [PubMed Central ID: PMC8069930]. https://doi.org/10.3390/molecules26082193.
-
22.
Aljeldah MM. Antimicrobial Resistance and Its Spread Is a Global Threat. Antibiotics (Basel). 2022;11(8). [PubMed ID: 36009948]. [PubMed Central ID: PMC9405321]. https://doi.org/10.3390/antibiotics11081082.
-
23.
Murugaiyan J, Kumar PA, Rao GS, Iskandar K, Hawser S, Hays JP, et al. Progress in Alternative Strategies to Combat Antimicrobial Resistance: Focus on Antibiotics. Antibiotics (Basel). 2022;11(2). [PubMed ID: 35203804]. [PubMed Central ID: PMC8868457]. https://doi.org/10.3390/antibiotics11020200.
-
24.
Lombardino JG, Lowe J3. The role of the medicinal chemist in drug discovery--then and now. Nat Rev Drug Discov. 2004;3(10):853-62. [PubMed ID: 15459676]. https://doi.org/10.1038/nrd1523.
-
25.
Zhang Z, Tang W. Drug metabolism in drug discovery and development. Acta Pharm Sin B. 2018;8(5):721-32. [PubMed ID: 30245961]. [PubMed Central ID: PMC6146880]. https://doi.org/10.1016/j.apsb.2018.04.003.
-
26.
Shanu-Wilson J, Evans L, Wrigley S, Steele J, Atherton J, Boer J. Biotransformation: Impact and Application of Metabolism in Drug Discovery. ACS Med Chem Lett. 2020;11(11):2087-107. [PubMed ID: 33214818]. [PubMed Central ID: PMC7667663]. https://doi.org/10.1021/acsmedchemlett.0c00202.